Optimisation of anti-cancer peptide vaccines to preferentially elicit high-avidity T cells (Q2288459)
From MaRDI portal
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Optimisation of anti-cancer peptide vaccines to preferentially elicit high-avidity T cells |
scientific article |
Statements
Optimisation of anti-cancer peptide vaccines to preferentially elicit high-avidity T cells (English)
0 references
20 January 2020
0 references
melanoma
0 references
cancer vaccines
0 references
optimisation
0 references
vaccine efficiency
0 references
T-cell avidity
0 references
CTL avidity
0 references
avidity
0 references
